Medications for pulmonary embolism may decrease the size of blood clots, help dissolve them, or reduce the risk of recurrence. All of these medications carry the risk of bleeding. A pulmonary ...

Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...

Penumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...

Shatti, head of the Cardiac Catheterization Unit at Al-Dabous Center at Al-Adan Hospital, announced that the hospital has ...

Inquis Medical has raised $40 million in funding to support the development of its mechanical blood clot removal system. | ...

The Aventus thrombectomy system uses technology that tells the operator if the device’s tip is in contact with blood, a clot ...

Hyperbaric Oxygen Therapy Devices MarketIn 2023, the global market for hyperbaric oxygen therapy devices is projected to be ...

Re-expansion pulmonary oedema (RPE) is an uncommon complication that occurs when a collapsed lung suddenly re-expands, resulting in an osmotic shift of fluid from the blood vessels into the air spaces ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Baron Funds, an investment management company, released its “Baron Discovery Fund” third quarter 2024 investor letter. A copy ...

Akura Medical, a Shifamed portfolio company, announced today that the FDA granted its Katana system investigational device exemption (IDE).